A new trial shows that adding the glucagon‐like peptide 1 analog semaglutide to diet and exercise leads to weight loss.
References
Elgot, J. The Guardian https://www.theguardian.com/society/2015/may/31/obesity-new-smoking-nhs-england-chief-executive (31 May 2015).
Wilding, J. P. H. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2032183 (2021).
Goettler, A., Grosse, A. & Sonntag, D. BMJ Open 7, e014632 (2017).
National Institute of Health and Care Excellence. https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/technology-appraisal-processes-guide-apr-2018.pdf (April 2018).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03693430 (2021).
National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health-topics/overweight-and-obesity
Marso, S. P. et al. N. Engl. J. Med 375, 1834–1844 (2016).
Ryan, D. H. et al. Am. Heart J. 229, 61–69 (2020).
Kolotkin, R. L. & Andersen, J. R. Clin. Obes 7, 273–289 (2017).
National Institute of Health and Care Excellence. https://www.nice.org.uk/guidance/ta664 (9 December 2020).
Sandman, L. & Hansson, E. BMC Med. Ethics 21, 94 (2020).
National Institute of Health and Care Excellence. https://www.nice.org.uk/guidance/cg189 (27 November 2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.I.A. receives partial salary support from the National Institute of Health and Care Excellence and the NIHR Oxford Biomedical Research Centre.
Rights and permissions
About this article
Cite this article
Adler, A.I. The STEP 1 trial for weight loss: a step change in treating obesity?. Nat Med 27, 589–590 (2021). https://doi.org/10.1038/s41591-021-01319-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01319-4
- Springer Nature America, Inc.